The Discounted Cash Flow (DCF) valuation of Zhejiang Shapuaisi Pharmaceutical Co Ltd (603168.SS) is 3.18 CNY. With the latest stock price at 7.46 CNY, the upside of Zhejiang Shapuaisi Pharmaceutical Co Ltd based on DCF is -57.4%.
Based on the latest price of 7.46 CNY and our DCF valuation, Zhejiang Shapuaisi Pharmaceutical Co Ltd (603168.SS) is a sell. selling 603168.SS stocks now will result in a potential gain of 57.4%.
| Range | Selected | |
| WACC / Discount Rate | 7.1% - 10.6% | 8.8% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 2.07 - 7.29 | 3.18 |
| Upside | -72.3% - -2.3% | -57.4% |